Opocrin Overview

  • Year Founded
  • 1964

Year Founded

  • Status
  • Private

  • Employees
  • 273

Employees

  • Latest Deal Type
  • Debt - Acquisition

Opocrin General Information

Description

Manufacturer of pharmaceutical products based in Italy. The company specializes in the research, production and marketing of active pharmaceutical ingredients derived from animal organs and tissues including the production of iron complexes such as sodium ferric gluconate, iron sucrose and ferric protein.

Contact Information

Website
www.opocrin.it
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Corporate Office
  • Strada Scaglia Estate 5
  • 41126 Modena
  • Italy
+39 059
Primary Industry
Drug Discovery
Other Industries
BPO/Outsource Services
Vertical(s)
Corporate Office
  • Strada Scaglia Estate 5
  • 41126 Modena
  • Italy
+39 059

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Opocrin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Debt - Acquisition 14-Feb-2020 Completed Generating Revenue
To view Opocrin’s complete valuation and funding history, request access »

Opocrin Patents

Opocrin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3331492-B1 Compositions comprising dermatan sulfate and chondroitin sulfate Active 07-Aug-2015
EP-3331492-C0 Compositions comprising dermatan sulfate and chondroitin sulfate Active 07-Aug-2015
EP-3331492-A1 Compositions comprising dermatan sulfate and chondroitin sulfate and use thereof in cosmetological compositions Active 07-Aug-2015
AU-2016304201-A1 Compositions comprising dermatan sulfate and chondroitin sulfate and use thereof in cosmetological compositions Active 06-Aug-2015
AU-2016304201-B2 Compositions comprising dermatan sulfate and chondroitin sulfate and use thereof in cosmetological compositions Active 06-Aug-2015 A61K8/735
To view Opocrin’s complete patent history, request access »

Opocrin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Opocrin Investments & Acquisitions (2)

Opocrin’s most recent deal was a Merger/Acquisition with Laboratori Derivati Organic. The deal was made on 14-Feb-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Laboratori Derivati Organic 14-Feb-2020 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Dilafor 23-Apr-2019 Later Stage VC Drug Discovery
To view Opocrin’s complete investments and acquisitions history, request access »

Opocrin Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Omikron (Pharmaceuticals) Rome, Italy 2005

Opocrin FAQs

  • When was Opocrin founded?

    Opocrin was founded in 1964.

  • Where is Opocrin headquartered?

    Opocrin is headquartered in Modena, Italy.

  • What is the size of Opocrin?

    Opocrin has 273 total employees.

  • What industry is Opocrin in?

    Opocrin’s primary industry is Drug Discovery.

  • Is Opocrin a private or public company?

    Opocrin is a Private company.

  • What is Opocrin’s current revenue?

    The current revenue for Opocrin is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process